Skip to content
Home/Companies/Pharma/Saphar

Saphar

Pharma·Niger·Exited 2011·Held 5yr
Entry
2006
Hold
5yr
Exit
2011

Who owns Saphar?

Saphar was owned by Investisseurs et Partenaires through IPDEV 1 (2002 vintage) from 2006 to 2011, exited via MBO.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-11

Investisseurs et Partenaires
Investor
Investisseurs et Partenaires
IPDEV 1 · 2002 · Growth

Key facts

HQNiger
SectorPharma
StatusAcquired
Exit Type
MBO
Buyer
MOIC
–
Exit Year
2011

More from IPDEV 1

Other portfolio companies in the same fund.

Normat
Exited 2021
IndustrialsBenin· 2017
to
Nutrizaza
Exited 2017
ConsumerMadagascar· 2012
to
CDS
Exited 2016
EnergyMauritania· 2011
to
Fides Microfinance Senegal
Exited 2018
FinancialsSenegal· 2011
to
Duopharm
Exited 2016
PharmaSenegal· 2010
to
Fides Bank Namibia
Exited 2014
FinancialsNamibia· 2010
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
Laboratoires Delbert
Active
SocadifFrance
Pharmathen
Active
Partners GroupGreece
AMW
AMW
Active
SHS Gesellschaft für BeteiligungsmanagementGermany· 2026
Basic Pharma
Active
SHS Gesellschaft für BeteiligungsmanagementNetherlands· 2026
Biogaran
Biogaran
Active
Bpifrance InvestissementFrance· 2026
Track Saphar

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Saphar?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Saphar.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue